Mihaela Moisei

Dr. Mihaela Moisei

Department of Dental Medicine, "Dunarea de Jos" University of Galati, Galaţi, Romania

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MNMunteanu Sorina Nicoleta
Munteanu Sorina Nicoleta
ASAdrian Stan
Adrian Stan
ANAurel Nechita
Aurel Nechita
DFDorel Firescu
Dorel Firescu
MCMarinescu Mihai Cristian
Marinescu Mihai Cristian
ARAURELIA ROMILA
AURELIA ROMILA
Background and Objectives: Biological correlates of baseline clinical responsiveness remain incompletely characterized in older adults with acute ischemic stroke treated with intravenous thrombolysis. We evaluated associations between admission Glasgow Coma Scale (GCS) and pre-thrombolysis hematologic, inflammatory, iron-status, and micronutrient parameters. Materials and Methods: This retrospective single-center cohort included 95 unique patients aged ≥65 years, all treated with intravenous alteplase between 2020 and 2024. Admission GCS ranged from 11 to 14. Spearman correlations used original GCS scores. Principal proportional odds models used ordered GCS categories of 11–12, 13, and 14, and were adjusted for age, sex, and admission National Institutes of Health Stroke Scale (NIHSS), with false discovery rate corrections. Sensitivity analyses additionally considered clinician-documented aphasia, congestive heart failure, atrial fibrillation, and reperfusion status for 24 h GCS change. Results: Admission GCS correlated most strongly with RDW-CV (rho = −0.843; 95% bootstrap CI, −0.892 to −0.774) and MCV (rho = 0.779; 95% CI, 0.668 to 0.866). Principal adjusted odds ratios per one-SD increase were 5.68 for hemoglobin, 3.01 for log-transformed ferritin, 4.71 for serum iron, 4.71 for log-transformed vitamin B12, 0.20 for C-reactive protein, and 0.019 for RDW-CV (all FDR-adjusted p < 0.001). Association directions remained consistent in sensitivity analyses. MCV showed an exploratory nonlinear association. No biomarker was associated with the direction of 24 h GCS change after FDR correction, including reperfusion-adjusted models. Conclusions: Pre-thrombolysis biological parameters were concurrently associated with baseline GCS within this single-center cohort and restricted GCS range. These associations do not establish causality, independence from unmeasured lesion location or infarct volume, predictive utility, or early neurological recovery. Prospective external validation is required.

22 July 2026 in Medicina
Verified
Journal Article
Open access
PDF file
ASAdrian Stan
Adrian Stan
MMMihaela Moisei
Mihaela Moisei
LPLiliana Lăcrămioara Pavel
Liliana Lăcrămioara Pavel
Mititelu-Tartau LilianaMititelu-Tartau Liliana
Mititelu-Tartau Liliana
BBBuca Beatrice-Rozalina
Buca Beatrice-Rozalina
MDMioara Decusară
Mioara Decusară
Background and Objectives: Diabetes mellitus is a major systemic modifier of oral infection, periodontal inflammation, and tissue healing. Persistent hyperglycemia may intensify oxidative stress, immune dysfunction, dysbiotic biofilm activity, and advanced glycation end-product/receptor signaling, thereby reducing the predictability of periapical and periodontal healing. In patients with endo-periodontal lesions, these mechanisms may interact with pulpal infection and periodontal breakdown, complicating diagnosis, prognosis, and therapeutic sequencing. This review summarizes current evidence on diabetes, glycated hemoglobin (HbA1c), and endo-periodontal outcomes and proposes an HbA1c-guided clinical framework for risk stratification and treatment planning. Materials and Methods: A structured narrative review with an expert-informed clinical framework was conducted using the literature published between January 2016 and December 2025. Eligible sources included consensus reports, clinical practice guidelines, systematic reviews, meta-analyses, umbrella reviews, randomized and non-randomized clinical studies, observational studies, and selected mechanistic studies or contemporary narrative reviews with direct relevance to the framework. Case reports, animal studies, and in vitro investigations without direct relevance to the clinical framework were excluded from the main synthesis. Results: Diabetes is associated with increased periodontal severity, impaired periodontal treatment response, a higher prevalence of radiolucent periapical lesions in root-filled teeth, delayed periapical healing, and increased non-retention of endodontically treated teeth. Periodontal therapy is safe in diabetic patients and may be associated with modest reductions in HbA1c, especially when baseline metabolic control is poor. Conclusions: HbA1c should complement, not replace, pulpal testing, periodontal charting, and radiographic assessment. The proposed framework prioritizes endodontic infection control when pulpal necrosis or active intracanal infection is present, adapts periodontal intervention to metabolic risk, and postpones elective surgical or regenerative procedures in poorly controlled diabetes until medical stabilization is achieved.
1

5 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ASAdrian Stan
Adrian Stan
MMMihaela Moisei
Mihaela Moisei
MNMunteanu Sorina Nicoleta
Munteanu Sorina Nicoleta
CPCatalin Plesea-Condratovici
Catalin Plesea-Condratovici
Mititelu-Tartau LilianaMititelu-Tartau Liliana
Mititelu-Tartau Liliana
LPLiliana Lăcrămioara Pavel
Liliana Lăcrămioara Pavel
Monoclonal antibody-based therapies are widely used in chronic immune-mediated diseases, yet periodontal effects, dentoalveolar safety signals and exposure characteristics remain incompletely characterized. This scoping review mapped periodontal outcomes, safety signals, administration, exposure and pharmaceutical-context reporting in adults. PubMed, Scopus and Web of Science were searched in July 2026 without publication-year or language restrictions. Sources were selected using Population, Concept and Context criteria, appraised with design-specific Joanna Briggs Institute tools and synthesized by therapeutic target. Of 1154 records, 21 reports representing 20 studies or cohort families were included. Evidence concentrated on rheumatoid arthritis and therapies targeting tumour necrosis factor, interleukin-6 receptor, cluster of differentiation 20, or interleukin-17A. Tocilizumab showed the most consistent reductions in gingival inflammation and bleeding on probing, whereas structural changes were smaller and inconsistent. Tumour necrosis factor-directed findings were heterogeneous; small rituximab studies showed favourable clinical or biomarker signals, while pharmacovigilance contained infectious and destructive dentoalveolar signals. Intravenous and subcutaneous administration were represented, but exposure reporting was incomplete. No included periodontal study evaluated formulation stability, storage, cold-chain integrity, or handling deviations. Risk-based periodontal surveillance may accompany therapy, but validated protocols cannot be defined. The identified gap concerns integrating pharmaceutical-context variables into periodontal research, not monoclonal-antibody stability research generally.
1

8 September 2026 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
ASAdrian Stan
Adrian Stan
MNMunteanu Sorina Nicoleta
Munteanu Sorina Nicoleta
CPCatalin Plesea-Condratovici
Catalin Plesea-Condratovici
Mititelu-Tartau LilianaMititelu-Tartau Liliana
Mititelu-Tartau Liliana
BBBuca Beatrice-Rozalina
Buca Beatrice-Rozalina
MMMihaela Moisei
Mihaela Moisei
Monoclonal antibody-based therapies are widely used in chronic immune-mediated diseases, but their periodontal effects, dentoalveolar safety signals, and exposure characteristics remain incompletely characterized. This scoping review mapped periodontal clinical outcomes, biomarkers, microbiological and imaging findings, dentoalveolar safety, administration, treatment exposure, and pharmaceutical-context reporting. PubMed, Scopus, and Web of Science were searched in July 2026 without publication-year or language restrictions. Twenty-one reports representing 20 studies or cohort families were included. Evidence mainly concerned rheumatoid arthritis and therapies targeting tumor necrosis factor, interleukin-6 receptor, and cluster of differentiation 20. Evidence for interleukin-17A inhibition was insufficient and derived from one confounded five-patient case series. Tocilizumab showed the most consistent reductions in gingival inflammation and bleeding on probing, while structural changes were smaller and inconsistent. Tumor necrosis factor-directed findings were heterogeneous. Small rituximab studies showed favorable clinical or biomarker signals, whereas pharmacovigilance identified infectious and destructive dentoalveolar signals. Exposure reporting was incomplete, and no included periodontal study evaluated formulation stability, storage, cold-chain integrity, or handling deviations. This review integrates treatment-effect evidence, safety signals, and exposure variables across antibody targets and identifies a pharmaceutical–periodontal reporting gap requiring prospective investigation.

5 December 2025 in Medicina
Verified
Journal Article
Open access
PDF file
LLLuminita Lazar
Luminita Lazar
DPDora Maria Popescu
Dora Maria Popescu
TDTimea Dako
Timea Dako
MMMihaela Moisei
Mihaela Moisei
Dorin GheorgheDorin Gheorghe
Dorin Gheorghe
ALAna Petra Lazar
Ana Petra Lazar
Background and Objectives: Orthodontic tooth movement triggers micro-trauma in the periodontal ligament, leading to a balanced process of bone resorption and apposition mediated by local inflammatory responses. Monitoring N-telopeptide levels in gingival crevicular fluid (GCF) and applying low-intensity laser biostimulation can help optimize mechanical loading, reduce adverse effects, and enhance tissue remodeling during treatment. Materials and Methods: This study had a split-mouth observational design. From 30 patients with ages between 20 and 50, with standardized fixed orthodontic treatment, GCF samples were collected from both control and laser-treated hemiarches before and 14 days after appliance activation. Low-intensity laser therapy (LLLT) was applied to selected sites to assess its effect on N-telopeptide levels, a marker of bone resorption, with samples analyzed via ELISA and results compared statistically to evaluate the impact of laser biostimulation during orthodontic treatment. Statistical analysis was performed using paired t-tests or Wilcoxon tests for two-group comparisons. Results: N-telopeptide levels in gingival crevicular fluid increased significantly from baseline (T0) to 14 days (T1) in both the laser-treated (HL) and control (sham) hemiarches (HC), with higher values observed in the lasered side. Statistical analysis confirmed significant differences between HL and HC at T1 (p < 0.0001), as well as between each T1 group and baseline, indicating that low-intensity laser therapy enhanced bone resorption activity during orthodontic tooth movement. Conclusions: N-telopeptide exhibited higher values in the hemiarches where laser therapy was applied than in the control ones. This provides a rationale for using laser biostimulation as an adjuvant during orthodontic treatment to modulate tissue restructuring.
1

31 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MNMunteanu Sorina Nicoleta
Munteanu Sorina Nicoleta
ASAdrian Stan
Adrian Stan
ANAurel Nechita
Aurel Nechita
DFDorel Firescu
Dorel Firescu
MCMarinescu Mihai Cristian
Marinescu Mihai Cristian
ARAURELIA ROMILA
AURELIA ROMILA
Background and Objectives: Biological correlates of admission consciousness remain incompletely characterized in older adults with acute ischemic stroke treated with intravenous thrombolysis. We evaluated associations between admission Glasgow Coma Scale (GCS) and pre-thrombolysis hematologic, inflammatory, iron-status, and micronutrient parameters, while considering the oral-systemic relevance of the resulting biological pattern. Materials and Methods: This retrospective single-center cohort included 95 unique patients aged ≥65 years treated between 2020 and 2024. Spearman correlations used the original GCS scores (11–14). Proportional-odds models used ordered categories (11–12, 13, and 14), adjusted for age and sex, with additional National Institutes of Health Stroke Scale (NIHSS) adjustment; false discovery rate (FDR) correction was applied. Results: Admission GCS correlated most strongly with RDW-CV (rho = −0.843; 95% bootstrap CI, −0.892 to −0.774) and MCV (rho = 0.779; 95% CI, 0.668 to 0.866). In age- and sex-adjusted models, odds ratios per 1-SD increase were 5.15 for hemoglobin, 3.17 for log-transformed ferritin, 4.49 for serum iron, 4.90 for log-transformed vitamin B12, 0.18 for C-reactive protein, and 0.018 for RDW-CV (all FDR-adjusted p < 0.001). Directions remained consistent after NIHSS adjustment. MCV showed a nonlinear association, with a model-derived turning point at 86.6 fL. Biomarkers were associated with absolute GCS at 24 hours but not with the direction of 24-hour change after FDR correction. Conclusions: The pre-thrombolysis biological profile was associated with the restricted range of admission GCS observed in this cohort. The convergence of hematologic, micronutrient, and inflammatory associations provides an exploratory oral-systemic research perspective but does not establish oral disease or an oral source for the systemic findings.
1